Jazz Pharmaceuticals (JAZZ) EPS (Basic) (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Jazz Pharmaceuticals | 14.35 Bn | 12.51 Bn | 934.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 41.62% |
| Dec 31, 2025 | -19.32% |
| Sep 30, 2025 | 135.26% |
| Jun 30, 2025 | -672.37% |
| Mar 31, 2025 | -148.56% |
| Dec 31, 2024 | -10.57% |
| Sep 30, 2024 | 30.60% |
| Jun 30, 2024 | 1,265.22% |
| Mar 31, 2024 | -115.33% |
| Dec 31, 2023 | -35.62% |
| Sep 30, 2023 | 42.94% |
| Jun 30, 2023 | 49.54% |
| Mar 31, 2023 | 128.31% |
| Dec 31, 2022 | -1,141.94% |
| Sep 30, 2022 | -155.36% |
| Jun 30, 2022 | 1,766.67% |
| Mar 31, 2022 | 105.56% |
| Dec 31, 2021 | 37.21% |
| Sep 30, 2021 | 85.92% |
| Jun 30, 2021 | -382.87% |
| Mar 31, 2021 | -9.62% |
| Dec 31, 2020 | -10.49% |
| Sep 30, 2020 | 28.99% |
| Jun 30, 2020 | 173.40% |
| Mar 31, 2020 | -315.27% |
| Dec 31, 2019 | -27.22% |
| Sep 30, 2019 | -61.04% |
| Jun 30, 2019 | 210.07% |
| Mar 31, 2019 | -44.61% |
| Dec 31, 2018 | 8.91% |
| Sep 30, 2018 | 61.44% |
| Jun 30, 2018 | 98.70% |
| Mar 31, 2018 | -80.10% |
| Dec 31, 2017 | 265.09% |
| Sep 30, 2017 | -39.77% |
| Jun 30, 2017 | 22.22% |
| Mar 31, 2017 | -26.15% |
| Dec 31, 2016 | 30.87% |
| Sep 30, 2016 | -21.16% |
| Jun 30, 2016 | 52.42% |
| Mar 31, 2016 | -8.15% |
| Dec 31, 2015 | -5.59% |
| Sep 30, 2015 | -0.69% |
| Jun 30, 2015 | 24.14% |
| Mar 31, 2015 | -14.07% |
| Dec 31, 2014 | 213.95% |
| Sep 30, 2014 | -41.10% |
| Jun 30, 2014 | 146.20% |
| Mar 31, 2014 | -264.58% |
| Dec 31, 2013 | -26.15% |
| Sep 30, 2013 | 80.56% |
| Jun 30, 2013 | -2.70% |
| Mar 31, 2013 | -78.61% |
| Dec 31, 2012 | 496.55% |
| Sep 30, 2012 | 20.83% |
| Jun 30, 2012 | -5.88% |
| Mar 31, 2012 | -42.05% |
| Dec 31, 2011 | 14.29% |
| Sep 30, 2011 | -4.94% |
| Jun 30, 2011 | 50.00% |
| Mar 31, 2011 | -18.18% |
| Dec 31, 2010 | -14.29% |
| Sep 30, 2010 | -4.94% |